XML 98 R74.htm IDEA: XBRL DOCUMENT v3.10.0.1
Joint Ventures and Other Equity Method Affiliates - Termination of SPMSD (Details) - Step Acquisition and Termination of SPMSD
$ in Millions
12 Months Ended
Dec. 31, 2016
USD ($)
Business Acquisition [Line Items]  
Estimated useful life of intangible assets 8 years
Products and product rights (8-year useful life) $ 936
Accounts receivable 133
Income taxes payable (221)
Deferred income tax liabilities (147)
Other, net 47
Net assets acquired 748
Consideration payable to Sanofi, net (392)
Derecognition of Merck’s previously held equity investment in SPMSD (183)
Increase in net assets 173
Merck’s share of restructuring costs related to the termination (77)
Net gain on termination of SPMSD joint venture $ 96